In one paragraphArticle in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Brane GrambozovDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.ORCID 0000-0003-2454-7425 Nazanin Zamani-SiahkaliDivision of Molecular Imaging and Theranostics, Department of Nuclear Medicine, Paracelsus Medical University, SALK, A-5020 Salzburg, Austria.ORCID 0009-0003-9633-8312 Markus StanaDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.ORCID 0000-0002-0155-0384 Mohsen BeheshtiDivision of Molecular Imaging and Theranostics, Department of Nuclear Medicine, Paracelsus Medical University, SALK, A-5020 Salzburg, Austria.ORCID 0000-0003-3918-3812 Elvis RuznicDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.ORCID 0000-0001-7686-1008 Zarina IskakovaDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.
Josef KarnerDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.
Barbara ZellingerInstitute of Pathology, Paracelsus Medical University, SALK, A-5020 Salzburg, Austria.
Sabine GerumDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.
Falk RoederDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.
Christian PirichDepartment of Nuclear Medicine, Paracelsus Medical University, SALK, A-5020 Salzburg, Austria.ORCID 0000-0002-4502-0609 Franz ZehentmayrDepartment of Radiation Oncology, Paracelsus Medical University, SALK, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.ORCID 0000-0001-5931-3907 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
18F-FDG-PET-CTimage biomarkersnon-small cell lung cancerreirradiation
Identifiers
PMID40868121
PMCPMC12383723
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390